1. Home
  2. SPCB vs BSEM Comparison

SPCB vs BSEM Comparison

Compare SPCB & BSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$10.11

Market Cap

63.2M

Sector

Technology

ML Signal

HOLD

BSEM

BioStem Technologies Inc. Common Stock

N/A

Current Price

$3.71

Market Cap

59.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SPCB
BSEM
Founded
1988
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
63.2M
59.6M
IPO Year
2004
2026

Fundamental Metrics

Financial Performance
Metric
SPCB
BSEM
Price
$10.11
$3.71
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
111.8K
114.1K
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.13
N/A
P/E Ratio
$10.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.07
$2.25
52 Week High
$13.57
$4.66

Technical Indicators

Market Signals
Indicator
SPCB
BSEM
Relative Strength Index (RSI) 41.64 46.76
Support Level $7.89 $2.25
Resistance Level $10.78 $4.02
Average True Range (ATR) 0.47 0.33
MACD -0.08 0.03
Stochastic Oscillator 15.03 70.01

Price Performance

Historical Comparison
SPCB
BSEM

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

About BSEM BioStem Technologies Inc. Common Stock

BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.

Share on Social Networks: